Public ownership evidence

PharmaCyte Biotech, Inc. Common Stock (PMCB) Ownership Disclosures

Read PMCB insider transactions, institutional 13F filings and Congressional disclosures with report dates, public availability and original receipts.

As of 2026-10-10T12:08:28.848Z

Separate the three disclosure sources

Step 1 of 3

Recent institutional filing receipts

PharmaCyte Biotech, Inc. Common Stock: source evidence dated 2026-10-10T12:08:28.848Z.

Manager
XTX Topco Ltd
Report period
2026-06-30
Available
2026-08-15
Reported shares
34,180
Value (USD)
$26,319
Option
None
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Is this an insider transaction, 13F holding, or Congressional event?

Each source has different dates and units. Raw ticker-matched receipts, including amendments, are not deduplicated current ownership totals.

13F 0001828301-26-000005
What you should see

Follow the source receipt or manager/member profile. Avoid combining transaction value and 13F position value into an ownership percentage.

Step 3 of 3

Read PMCB fundamentals

Follow the source receipt or manager/member profile. Avoid combining transaction value and 13F position value into an ownership percentage.

Read PMCB fundamentals
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Recent Form 4 activity

No matching purchases, sales or awards were returned in this 90-day public filing window.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

90-day public availability window, up to 50 records.

Recent institutional filing receipts

See the complete recent institutional filing receipts

These are raw ticker-matched positions in recent 13F receipts, including amendments. They are not deduplicated current ownership totals. Open the manager profile to inspect its effective filing book.

Scroll sideways to compare all columns. Select a heading to sort.

XTX Topco Ltd2026-06-302026-08-1534,180$26,319None
OSAIC HOLDINGS, INC.2026-06-302026-08-151$1None
OSAIC HOLDINGS, INC.2026-06-302026-08-15302$231None
Schonfeld Strategic Advisors LLC2026-06-302026-08-1526,926$20,733None
JANE STREET GROUP, LLC2026-06-302026-08-153,479$2,679None
JANE STREET GROUP, LLC2026-06-302026-08-1526,585$20,470None
HRT FINANCIAL LP2026-06-302026-08-1515,451$11,000None
SUSQUEHANNA INTERNATIONAL GROUP, LLP2026-06-302026-08-1511,094$8,542None
SUSQUEHANNA INTERNATIONAL GROUP, LLP2026-06-302026-08-1533,759$25,994None
CITADEL ADVISORS LLC2026-06-302026-08-15283,381$218,203None
CITADEL ADVISORS LLC2026-06-302026-08-1586,100$66,297Call
GROUP ONE TRADING LLC2026-06-302026-08-15500$385None
BARCLAYS PLC2026-06-302026-08-15192$148None
VANGUARD CAPITAL MANAGEMENT LLC2026-06-302026-08-1456,778$43,719None
UBS Group AG2026-06-302026-08-144,112$3,166None
UBS Group AG2026-06-302026-08-1430$23None
RENAISSANCE TECHNOLOGIES LLC2026-06-302026-08-1437,987$29,250None
VANGUARD FIDUCIARY TRUST CO2026-06-302026-08-1423,452$18,058None
MORGAN STANLEY2026-06-302026-08-141$1None
MORGAN STANLEY2026-06-302026-08-141$1None
NORTHERN TRUST CORP2026-06-302026-08-1432,624$25,120None
MCF Advisors LLC2026-06-302026-08-131$1None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-1320,060$15,446None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-13104,187$80,235None
NewEdge Advisors, LLC2026-06-302026-08-132$2None
HARBOUR INVESTMENTS, INC.2026-06-302026-08-133$2None
Tower Research Capital LLC (TRC)2026-06-302026-08-124,888$3,764None
Johnson Financial Group, Inc.2026-06-302026-08-111$1None
BlackRock, Inc.2026-06-302026-08-081$1None
CALDWELL SUTTER CAPITAL, INC.2026-06-302026-08-062$2None
COMMONWEALTH EQUITY SERVICES, LLC2026-06-302026-07-3020,255$15,600None
SBI Securities Co., Ltd.2026-06-302026-07-246$5None
FINANCIAL CONSULATE, INC2026-06-302026-07-242$2None
BFSG, LLC2026-06-302026-07-215$4None
EQUITEC PROPRIETARY MARKETS, LLC2026-06-302026-07-2122,227$17,115None
Sachetta, LLC2026-06-302026-07-1614$11None

90-day public filing window, up to 50 source positions.

Recent Congressional disclosures

No matching Congressional transactions were returned in this source preview.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Bounded public source preview, up to 25 disclosed events.

How to read the disclosure dates

The tables report different things: insider transactions, institutional positions and Congressional transaction ranges. Read each table with its source dates and units. They cannot be added into a combined ownership percentage.

  1. Company insiders

    SEC Form 4 purchases, sales and awards report transactions and their public filing availability.

  2. Institutional managers

    13F reports disclose delayed quarter-end positions. They are not a record of trades between quarters.

  3. Congressional filers

    Periodic transaction reports disclose transaction dates and amount brackets. Public filing dates determine what researchers could know.

Read the transaction codes

Awards use transaction code A, purchases P and sales S. An acquisition from an award is not the same as an open-market purchase. Joint filers may share a transaction. Use original receipts and availability dates to interpret the events.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.